Report Overview:
The Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size was estimated at USD 8110.25 million in 2023 and is projected to reach USD 9797.43 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.
This report provides a deep insight into the global Diagnostic Radiopharmaceuticals and Contrast Media market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Diagnostic Radiopharmaceuticals and Contrast Media Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Diagnostic Radiopharmaceuticals and Contrast Media market in any manner.
Global Diagnostic Radiopharmaceuticals and Contrast Media Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion
Market Segmentation (by Type)
Radiopharmaceuticals
Contrast Media
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Diagnostic Radiopharmaceuticals and Contrast Media Market
? Overview of the regional outlook of the Diagnostic Radiopharmaceuticals and Contrast Media Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Radiopharmaceuticals and Contrast Media Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Diagnostic Radiopharmaceuticals and Contrast Media
1.2 Key Market Segments
1.2.1 Diagnostic Radiopharmaceuticals and Contrast Media Segment by Type
1.2.2 Diagnostic Radiopharmaceuticals and Contrast Media Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Diagnostic Radiopharmaceuticals and Contrast Media Market Overview
2.1 Global Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Diagnostic Radiopharmaceuticals and Contrast Media Market Competitive Landscape
3.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Manufacturers (2019-2024)
3.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Revenue Market Share by Manufacturers (2019-2024)
3.3 Diagnostic Radiopharmaceuticals and Contrast Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diagnostic Radiopharmaceuticals and Contrast Media Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Diagnostic Radiopharmaceuticals and Contrast Media Sales Sites, Area Served, Product Type
3.6 Diagnostic Radiopharmaceuticals and Contrast Media Market Competitive Situation and Trends
3.6.1 Diagnostic Radiopharmaceuticals and Contrast Media Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diagnostic Radiopharmaceuticals and Contrast Media Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Diagnostic Radiopharmaceuticals and Contrast Media Industry Chain Analysis
4.1 Diagnostic Radiopharmaceuticals and Contrast Media Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Diagnostic Radiopharmaceuticals and Contrast Media Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Diagnostic Radiopharmaceuticals and Contrast Media Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Type (2019-2024)
6.3 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Market Share by Type (2019-2024)
6.4 Global Diagnostic Radiopharmaceuticals and Contrast Media Price by Type (2019-2024)
7 Diagnostic Radiopharmaceuticals and Contrast Media Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Sales by Application (2019-2024)
7.3 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD) by Application (2019-2024)
7.4 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Growth Rate by Application (2019-2024)
8 Diagnostic Radiopharmaceuticals and Contrast Media Market Segmentation by Region
8.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region
8.1.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region
8.1.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Region
8.2 North America
8.2.1 North America Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amag Pharmaceuticals
9.1.1 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.1.2 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.1.4 Amag Pharmaceuticals Business Overview
9.1.5 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
9.1.6 Amag Pharmaceuticals Recent Developments
9.2 Bayer Healthcare
9.2.1 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.2.2 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.2.4 Bayer Healthcare Business Overview
9.2.5 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
9.2.6 Bayer Healthcare Recent Developments
9.3 Bracco Imaging
9.3.1 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.3.2 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
9.3.5 Bracco Imaging Business Overview
9.3.6 Bracco Imaging Recent Developments
9.4 Daiichi Sankyo
9.4.1 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.4.2 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.4.4 Daiichi Sankyo Business Overview
9.4.5 Daiichi Sankyo Recent Developments
9.5 GE Healthcare
9.5.1 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.5.2 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.5.3 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.5.4 GE Healthcare Business Overview
9.5.5 GE Healthcare Recent Developments
9.6 Guerbet
9.6.1 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.6.2 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.6.3 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.6.4 Guerbet Business Overview
9.6.5 Guerbet Recent Developments
9.7 Lantheus
9.7.1 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.7.2 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.7.3 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.7.4 Lantheus Business Overview
9.7.5 Lantheus Recent Developments
9.8 Mallinckrodt
9.8.1 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.8.2 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.8.4 Mallinckrodt Business Overview
9.8.5 Mallinckrodt Recent Developments
9.9 Medtronic
9.9.1 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.9.2 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.9.3 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.9.4 Medtronic Business Overview
9.9.5 Medtronic Recent Developments
9.10 Nordion
9.10.1 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.10.2 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.10.3 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.10.4 Nordion Business Overview
9.10.5 Nordion Recent Developments
10 Diagnostic Radiopharmaceuticals and Contrast Media Market Forecast by Region
10.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast
10.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Country
10.2.3 Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Region
10.2.4 South America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Diagnostic Radiopharmaceuticals and Contrast Media by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals and Contrast Media by Type (2025-2030)
11.1.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Diagnostic Radiopharmaceuticals and Contrast Media by Type (2025-2030)
11.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Forecast by Application (2025-2030)
11.2.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units) Forecast by Application
11.2.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Diagnostic Radiopharmaceuticals and Contrast Media Market Size Comparison by Region (M USD)
Table 5. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Diagnostic Radiopharmaceuticals and Contrast Media Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Diagnostic Radiopharmaceuticals and Contrast Media Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals and Contrast Media as of 2022)
Table 10. Global Market Diagnostic Radiopharmaceuticals and Contrast Media Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Diagnostic Radiopharmaceuticals and Contrast Media Sales Sites and Area Served
Table 12. Manufacturers Diagnostic Radiopharmaceuticals and Contrast Media Product Type
Table 13. Global Diagnostic Radiopharmaceuticals and Contrast Media Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Diagnostic Radiopharmaceuticals and Contrast Media
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diagnostic Radiopharmaceuticals and Contrast Media Market Challenges
Table 22. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Type (K Units)
Table 23. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size by Type (M USD)
Table 24. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units) by Type (2019-2024)
Table 25. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Type (2019-2024)
Table 26. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD) by Type (2019-2024)
Table 27. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Share by Type (2019-2024)
Table 28. Global Diagnostic Radiopharmaceuticals and Contrast Media Price (USD/Unit) by Type (2019-2024)
Table 29. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units) by Application
Table 30. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size by Application
Table 31. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Application (2019-2024) & (K Units)
Table 32. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Application (2019-2024)
Table 33. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Application (2019-2024) & (M USD)
Table 34. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Share by Application (2019-2024)
Table 35. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Growth Rate by Application (2019-2024)
Table 36. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region (2019-2024) & (K Units)
Table 37. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Region (2019-2024)
Table 38. North America Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country (2019-2024) & (K Units)
Table 39. Europe Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region (2019-2024) & (K Units)
Table 41. South America Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region (2019-2024) & (K Units)
Table 43. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 44. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 45. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Amag Pharmaceuticals Business Overview
Table 47. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
Table 48. Amag Pharmaceuticals Recent Developments
Table 49. Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 50. Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 51. Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bayer Healthcare Business Overview
Table 53. Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
Table 54. Bayer Healthcare Recent Developments
Table 55. Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 56. Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 57. Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
Table 59. Bracco Imaging Business Overview
Table 60. Bracco Imaging Recent Developments
Table 61. Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 62. Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 63. Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Daiichi Sankyo Business Overview
Table 65. Daiichi Sankyo Recent Developments
Table 66. GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 67. GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 68. GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GE Healthcare Business Overview
Table 70. GE Healthcare Recent Developments
Table 71. Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 72. Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 73. Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Guerbet Business Overview
Table 75. Guerbet Recent Developments
Table 76. Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 77. Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 78. Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Lantheus Business Overview
Table 80. Lantheus Recent Developments
Table 81. Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 82. Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 83. Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Mallinckrodt Business Overview
Table 85. Mallinckrodt Recent Developments
Table 86. Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 87. Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 88. Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Medtronic Business Overview
Table 90. Medtronic Recent Developments
Table 91. Nordion Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
Table 92. Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
Table 93. Nordion Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Nordion Business Overview
Table 95. Nordion Recent Developments
Table 96. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Diagnostic Radiopharmaceuticals and Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Diagnostic Radiopharmaceuticals and Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Diagnostic Radiopharmaceuticals and Contrast Media Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Diagnostic Radiopharmaceuticals and Contrast Media Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Diagnostic Radiopharmaceuticals and Contrast Media Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals and Contrast Media
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD), 2019-2030
Figure 5. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD) (2019-2030)
Figure 6. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diagnostic Radiopharmaceuticals and Contrast Media Market Size by Country (M USD)
Figure 11. Diagnostic Radiopharmaceuticals and Contrast Media Sales Share by Manufacturers in 2023
Figure 12. Global Diagnostic Radiopharmaceuticals and Contrast Media Revenue Share by Manufacturers in 2023
Figure 13. Diagnostic Radiopharmaceuticals and Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Diagnostic Radiopharmaceuticals and Contrast Media Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Diagnostic Radiopharmaceuticals and Contrast Media Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Share by Type
Figure 18. Sales Market Share of Diagnostic Radiopharmaceuticals and Contrast Media by Type (2019-2024)
Figure 19. Sales Market Share of Diagnostic Radiopharmaceuticals and Contrast Media by Type in 2023
Figure 20. Market Size Share of Diagnostic Radiopharmaceuticals and Contrast Media by Type (2019-2024)
Figure 21. Market Size Market Share of Diagnostic Radiopharmaceuticals and Contrast Media by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Share by Application
Figure 24. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Application (2019-2024)
Figure 25. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Application in 2023
Figure 26. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Share by Application (2019-2024)
Figure 27. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Share by Application in 2023
Figure 28. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Growth Rate by Application (2019-2024)
Figure 29. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Region (2019-2024)
Figure 30. North America Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Country in 2023
Figure 32. U.S. Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Diagnostic Radiopharmaceuticals and Contrast Media Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Country in 2023
Figure 37. Germany Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Region in 2023
Figure 44. China Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (K Units)
Figure 50. South America Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Country in 2023
Figure 51. Brazil Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Diagnostic Radiopharmaceuticals and Contrast Media Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Share Forecast by Type (2025-2030)
Figure 65. Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Forecast by Application (2025-2030)
Figure 66. Global Diagnostic Radiopharmaceuticals and Contrast Media Market Share Forecast by Application (2025-2030)
